Professor Ric Price

Professor of global health; senior principal research fellow; staff specialist in infectious diseases and general medicine, Division of Medicine, Royal Darwin Hospital

Qualifications:

Medical Doctorate, University of London, 2000; Bachelor of Medicine and Bachelor of Surgery, University of Cambridge, 1989; Fellow of The Royal College of Pathologists, UK, 2008; Fellow of The Royal College of Physicians, UK, 2005; Fellow of The Royal Australian College of Physicians, 2004; Master of Arts, University of Cambridge, 1990; Bachelor of Arts, University of Cambridge, 1983.

Approved level of HDR supervision at Charles Darwin University:

Principal Supervisor for PhD

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Professor Ric Price is an infectious disease and general physician on the staff at the Royal Darwin Hospital. He holds a dual academic affiliation as professor of global health at the Menzies School of Health Research and professor of tropical medicine at the Centre of Tropical Medicine, University of Oxford, UK. 
 
His translational research program focuses on improving the diagnosis and management of multidrug resistant Plasmodium falciparum and Plasmodium vivax infections through a research agenda that spans clinical studies, epidemiology, health economics, pathophysiology, immunology, in vitro studies and molecular biology.
 
He is currently leading multicentred clinical trials in more than seven malaria endemic countries to optimise the use of primaquine for the radical cure of vivax malaria.
 
Professor Price chairs the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and the Vivax Working Group of the Asia-Pacific Malaria Elimination Network (APMEN). 
  1. The WWARN AL Study Group (2015). The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a pooled analysis of individual patient data. Lancet Infectious Diseases, 15(6), 692-702.

  2. Price,R.N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J.K., & White, N.J. (2014). Global extent of chloroquine-resistant Plasmodium vivax a systematic review and meta-analysis. Lancet Infectious Diseases, 14, 982-91.

  3. The WWARN DP Study Group (2013). The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data. PLoS Medicine, 10(12): e1001564.

  4. Douglas, N.M., Lampah, D.A., Kenangalem, E., Simpson, J.A., Poespoprodjo, J.R., Sugiarto, P., Anstey, N.M., & Price, R.N. (2013). Major burden of severe anemia from non-falciparum malaria species in southern Papua: A hospital-based surveillance study. PLoS Medicine, 10(12), e1001575.

  5. Douglas, N.M., Nosten, F., Ashley, E.A., Phaiphun, L., van Vugt, M., Singhasivanon, P., White, N.J., & Price, R.N. (2011). Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clinical Infectious Diseases 52(5), 612-620.

  6. Tjitra, E., Anstey, N.M., Sugiarto, P., Warikar, N., Kenangalem,E., Karyana, M., Lampah, D.A., & Price, R.N. (2008). Multidrug-resistant Plasmodium vivax malaria associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Medicine, 5(6): e128.

  7. Poespoprodjo, J.R., Fobia, W., Kenangalem, E., Lampah, D.A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey N.M., & Price, R.N. (2008). Adverse pregnancy outcomes in an area where multidrug-resistant P. falciparum and P. vivax infections are endemic. Clinical Infectious Diseases, 46(9), 1374-1381.

  8. Ratcliff, A., Siswantoro, H., Kenangalem, E., Maritsela, R., Wuwung, M., Laihad, F., Ebsworth, E.P., Anstey, N.M., Tjitra, E., & Price, R.N. (2007). Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. The Lancet, 369(9563), 757-765.

  9. Price, R.N., Uhlemann, A.C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N.J., Nosten, F., & Krishna, S. (2004). Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet, 364, 438-447.

  10. Price, R.N., Nosten, F., Luxemburger, C., ter Kuile, F.O., Chongsuphajaisiddhi,T., & White, N.J. (1996). Effects of artemisinin derivatives on malaria transmissibility. The Lancet, 347(9016), 1654-1658.
Click here to view more Ric Price publications in PubMed.
  1. ScienceNews | A newly approved drug could be a boon for treating malaria

    ScienceNews | A newly approved drug could be a boon for treating malaria

    Date

    The first new treatment in 60 years for a particularly stubborn kind of malaria is raising hopes that it might help eradicate the disease.

  2. Improving P. vivax malaria treatment

    Improving P. vivax malaria treatment

    Date

    A study, led by a team at Menzies School of Health Research in Australia, has assembled individual patient data from clinical trials conducted since 2000, investigating the effect of chloroquine dosing, combined with the partner drug primaquine, and the risk of recurrent malaria across different settings.

  3. NT News | Malaria breakthrough for NT

    NT News | Malaria breakthrough for NT

    Date

    NT News page 7 - 21 July 2018 | Report on The Lancet Infectious Diseases P.vivax paper.

  4. Xinhua News | "Radical cure" best treatment for common malaria: study

    Xinhua News | "Radical cure" best treatment for common malaria: study

    Date

    (Xinhua) -- Researchers have discovered that a "radical cure" is the best treatment for a type of malaria affecting 13 million people.

  5. New evidence supports radical treatment of  widespread form of malaria

    New evidence supports radical treatment of widespread form of malaria

    Date

    A team of malaria experts from a large international research collaboration has today published results supporting the need for a radical cure strategy to tackle one of the most debilitating forms of malaria caused by the Plasmodium vivax parasite.

  6. Australian support for eliminating malaria and health research in the Indo-Pacific

    Australian support for eliminating malaria and health research in the Indo-Pacific

    Date

    Australia is playing a leading role in supporting malaria elimination efforts, particularly in the Indo-Pacific. The Government's Stronger Systems for Health Security program is supporting practical, relevant research into fundamental health security challenges.

  7. Malaria victim facing double hand amputation considers legal action against GP

    Malaria victim facing double hand amputation considers legal action against GP

    Date

    Malaria expert Professor Ric Price, from the Menzies School of Health Research in Darwin, said advising travellers about the prevention of malaria was not straightforward.

  8. NT News | Brains Trust Born

    NT News | Brains Trust Born

    Date

    Researchers at Darwin's Menzies School of Health Research will play a key role in a new push to fight the scourge of malaria in the Asia-Pacific region.

  9. New Australian-led malaria research powerhouse gears up to hunt down malaria across the Asia-Pacific

    New Australian-led malaria research powerhouse gears up to hunt down malaria across the Asia-Pacific

    Date

    Australia will take a leadership role in the Asia-Pacific region in a new initiative to help our nearest neighbours rid the scourge of malaria, in a new National Health and Medical Research Council (NHMRC) Centre for Research Excellence in Malaria Elimination.

  10. Curious Darwin: Why is there no malaria in Australia's northern capital?

    Curious Darwin: Why is there no malaria in Australia's northern capital?

    Date

    Professor Ric Price is an expert in malaria who works at the Menzies School of Health Research in Darwin. He said the victory over malaria was a result of prompt and effective diagnosis, actions to control mosquito numbers, and close follow-up of people who returned home from overseas who were sick with malaria.

  11. Scientists complete the genome sequences of malaria parasites

    Scientists complete the genome sequences of malaria parasites

    Date

    An international team of scientists has sequenced the genomes of the final two species of malaria parasites. The findings have important implications for malaria eradication worldwide and will help researchers to develop new drugs and a vaccine.

  12. $2m grant to combat drug resistant malaria and tuberculosis

    $2m grant to combat drug resistant malaria and tuberculosis

    Date

    A $2m research grant to work towards the prevention, control and elimination of malaria and tuberculosis (TB) in Southeast Asia and the Pacific has been awarded to a consortium led by Menzies School of Health Research, in collaboration with Burnet Institute, the Department of Foreign Affairs and Trade announced today.

  13. Burnet Institute Director's Seminar | Part two

    Burnet Institute Director's Seminar | Part two

    Date

    Click here to view on YouTube

  14. Burnet Institute Director's Seminar | Part one

    Burnet Institute Director's Seminar | Part one

    Date

    Click to view on YouTube

  15. TerritoryQ: War on Malaria, Prof Ric Price and Prof Nicholas Anstey

    TerritoryQ: War on Malaria, Prof Ric Price and Prof Nicholas Anstey

    Date

    A medical team based in Darwin has put itself at the centre of the goal to eliminate malaria from the Asia-Pacific

  16. Research reveals extent of drug resistant vivax malaria

    Research reveals extent of drug resistant vivax malaria

    Date

    New research into the extent and nature of drug resistant malaria is hoping to benefit the millions of people worldwide who suffer from the potential deadly disease.

  17. Menzies contributes to key antimalarial recommendations from multinational network

    Menzies contributes to key antimalarial recommendations from multinational network

    Date

    A new study by a global collaborative platform for scientists and clinical researchers hopes to address antimalarial drug resistance which continues to hamper malaria control programs.

  18. ABC AM: New research into fighting malaria

    ABC AM: New research into fighting malaria

    Date

    Scientists say new research into malaria will help provide new ways to combat the deadly disease.

  19. Radio Australia: Hopes that genetic mapping will outwit malaria parasite

    Radio Australia: Hopes that genetic mapping will outwit malaria parasite

    Date

    Scientists say new research into the malaria parasite will provide drugs to combat the ways it's evolving to gain resistance to the current range of anti-malaria medicine.

  20. Aljazeera News: Call for global action to tackle Malaria

    Aljazeera News: Call for global action to tackle Malaria

    Date

    Countries around the world need to do more to fight the spread of malaria, according to a new report by the World Health Organisation (WHO).